Bill Amendment: IL SB1413 | 2023-2024 | 103rd General Assembly

NOTE: For additional amemendments please see the Bill Drafting List

---

Bill Title: PHARMACEUTICALS-SOCIAL MEDIA

Status: 2024-04-19 - Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments [SB1413 Detail]

Download: Illinois-2023-SB1413-Senate_Amendment_001.html

---

Sen. Sue Rezin

Filed: 2/23/2023

10300SB1413sam001 LRB103 28324 SPS 57793 a
AMENDMENT TO SENATE BILL 1413
AMENDMENT NO. ______. Amend Senate Bill 1413 by replacing
everything after the enacting clause with the following:
"Section 1. Short title. This Act may be cited as the Sale
of Pharmaceuticals on Social Media Act.
Section 5. Definition. As used in this Act:
"Individual" does not include a manufacturer or
distributor identified on the label of a drug approved under
the Federal Food, Drug, and Cosmetic Act, a biological product
licensed under the Public Health Service Act, or a drug
marketed in accordance with an over-the-counter monograph
under the Federal Food, Drug, and Cosmetic Act.
"Social media" has the same meaning as defined in Section
6-5 of the Liquor Control Act of 1934.
Section 10. Sale of pharmaceuticals on social media;

10300SB1413sam001 - 2 - LRB103 28324 SPS 57793 a
verification process. Notwithstanding any other provision of
law, no individual shall sell or advertise the sale of a
pharmaceutical on social media unless the individual has
completed the following verification process:
(1) the individual shall submit an image of both the
front and back of the individual's state-issued
identification card to the social media platform upon or
through which the pharmaceutical is to be sold or
advertised;
(2) a disclaimer must be included in any advertisement
for the pharmaceutical on the social media platform that
clearly discloses the name of the individual selling the
pharmaceutical;
(3) the individual must be identified on the social
media page upon which the pharmaceutical is being sold or
advertised; and
(4) the individual must display a disclaimer on the
individual's main page on the social media platform
stating that the owner or operator sells or advertises the
pharmaceutical on that social media platform.".